Dated, but still relevant: Australian Pharmaceutical Benefits Scheme uses economic evaluations on the price of drugs. The US equivalent, the Federal Supply Schedule does not use such pricing references. As a result the most prescribed pharmaceutical drugs in the US can be between 79% and 306% more expensive than in Australia. https://australiainstitute.org.au/report/comparing-drug-prices-in-australia-and-the-usa-the-implications-of-the-us-australia-free-trade-agreement/ Agree, the Guardian is one of the best left.